Evidence map›Paper›PMID 38243297›Full record

ArticleBiology of sex differences2024

Sex-specific differences in intestinal microbiota associated with cardiovascular diseases.

Helena Garcia-Fernandez, Antonio P Arenas-de Larriva, Javier Lopez-Moreno, Francisco M Gutierrez-Mariscal, Juan L Romero-Cabrera, Helena Molina-Abril, Jose D Torres-Peña, Diego Rodriguez-Cano, Maria M Malagon, Jose M Ordovas and 4 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Biology of sex differences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00924937 nacompletednot on this map

Randomized Clinical Trial on the Effects of Mediterranean Diet (Rich on Olive Oil) in the Reduction of Coronary Events of Patients With Coronary Disease

TypeinterventionalSponsorHospital Universitario Reina Sofia de CordobaRan2009 to 2021Enrolled1,002ConditionsMyocardial Infarction, Unstable Angina, Malignancy, Cognitive DeclineArmsMediterranean Diet, Low Fat Diet
NCT07530575 naactive not recruitingnot on this mapstarted 2026, after this paper: background citation

Biological Effects of the Consumption of Limosilactobacillus Fermentum CRL 1446 - CONICET in Volunteers With Cardiovascular Risk Factors

TypeinterventionalSponsorPINER Pastor Manfredi WineryRan2026 to 2027Enrolled80ConditionsDisbiosis, Obesity, Overweight (BMI > 25), Hypertension (Without Type 2 Diabetes Mellitus)ArmsLimosilactobacillus fermentum 1446 CRL CONICET 2.20E+9 CFU, Placebo (inert excipient)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Helena Garcia-Fernandez *Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Antonio P Arenas-de Larriva *Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Javier Lopez-MorenoLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Francisco M Gutierrez-MariscalLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Juan L Romero-CabreraLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Helena Molina-AbrilDepartment of Applied Mathematics I, University of Seville, Seville, Spain.
Jose D Torres-PeñaLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Diego Rodriguez-CanoClinical Analysis Service, Reina Sofia University Hospital, Cordoba, Spain.
Maria M MalagonMaimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.
Jose M OrdovasCIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Javier Delgado-ListaLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Pablo Perez-MartinezLipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Jose Lopez-Miranda *Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain. jlopezmir@uco.es.
Antonio Camargo *Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain. antonio.camargo@imibic.org.ORCID 0000-0002-0415-4184
Instituto de Salud Carlos III · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESHospital Universitario Reina Sofía · ESTufts University · USUniversidad de Sevilla · ES

Funding

Consejería de Salud y Familias, Junta de Andalucía PI-0055-2021Instituto de Salud Carlos III CP14/00114Instituto de Salud Carlos III CPII19/00007Instituto de Salud Carlos III DTS19/00007Instituto de Salud Carlos III PI22/00925Instituto de Salud Carlos III PIE14/00005Instituto de Salud Carlos III PIE14/00031Ministerio de Ciencia e Innovación AGL2012/39615Ministerio de Ciencia e Innovación PID2019-104362RB-IooSecretaría de Estado de Investigación, Desarrollo e Innovación AGL2015-67896-PServicio Andaluz de Salud C1-0001-2022the Fundacion Patrimonio Comunal Olivarero Cordioprev-CEAS, 1/2016
6 · The paper itself

Abstract

backgroundCardiovascular diseases (CVD), including coronary heart disease (CHD), display a higher prevalence in men than women. This study aims to evaluate the variations in the intestinal microbiota between men and women afflicted with CHD and delineate these against a non-CVD control group for each sex.

methodsOur research was conducted in the framework of the CORDIOPREV study, a clinical trial which involved 837 men and 165 women with CHD. We contrasted our findings with a reference group of 375 individuals (270 men, 105 women) without CVD. The intestinal microbiota was examined through 16S metagenomics on the Illumina MiSeq platform and the data processed with Quiime2 software.

resultsOur results showed a sex-specific variation (beta diversity) in the intestinal microbiota, while alpha-biodiversity remained consistent across both sexes. Linear discriminant analysis effect size (LEfSe) analysis revealed sex-centric alterations in the intestinal microbiota linked to CVD. Moreover, using random forest (RF) methodology, we identified seven bacterial taxa-g_UBA1819 (Ruminococcaceae), g_Bilophila, g_Subdoligranulum, g_Phascolarctobacterium, f_Barnesiellaceae, g_Ruminococcus, and an unknown genus from the Ruminococcaceae family (Ruminococcaceae incertae sedis)-as key discriminators between men and women diagnosed with CHD. The same taxa also emerged as critical discriminators between CHD-afflicted and non-CVD individuals, when analyzed separately by sex.

conclusionOur findings suggest a sex-specific dysbiosis in the intestinal microbiota linked to CHD, potentially contributing to the sex disparity observed in CVD incidence. Trial registration Clinical Trials.gov.Identifier NCT00924937.

Indexed as

Cardiovascular DiseasesGastrointestinal MicrobiomeBacteriaFemaleHumansIncidenceMaleSex CharacteristicsCardiovascular diseasesCORDIOPREVDysbiosisGut microbiotaSexual dimorphism

Identifiers

PMID38243297
PMCPMC10797902
OpenAlexW4391032448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.